Matsuda, Yoshinori <br/><br/>
Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer.  [electronic resource] 

 -  BMC cancer  Apr 2020 
 - 302 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-020-06844-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--genetics<br/>Cell Line, Tumor<br/>Cell Nucleus<br/>Cell Proliferation<br/>Docetaxel--therapeutic use<br/>Gene Knockdown Techniques<br/>Humans<br/>Male<br/>Neoadjuvant Therapy<br/>Neoplasm, Residual--drug therapy<br/>Prostatic Neoplasms--drug therapy<br/>Survival Analysis<br/>Tissue Array Analysis<br/>Transcription Factors--genetics<br/>Up-Regulation<br/>YAP-Signaling Proteins